Press Room

Share

New Medicare Drug Rule Could Leave Patients Unable to Access Needed Medications

September 14, 2020

Washington, D.C.—The Trump administration issued an executive order Sunday that would significantly change how Medicare pays for certain prescription drugs. The “Most Favored Nation” policy would tie Medicare drug reimbursement for certain drugs under Part B and D to that of prices paid in select foreign countries.  

A statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN) follows: 

“ACS CAN shares the underlying goal of making prescription drugs more affordable. However, the executive order involving Medicare drug coverage creates significant questions around drug accessibility, which could potentially make it much harder for cancer patients to get the drugs necessary to treat their disease. The United States is often the first to approve innovative new cancer therapies and it is unclear how or whether such therapies would be covered by Medicare should the program’s payment mechanism be tied to countries that have not yet approved or have declined to pay for these drugs.    

“The countries included through the Most Favored Nation policy have significant differences in their health systems and supply chains and the policy does not appear to take these differences into account. Imposing such significant changes—especially in such a short timeframe—could mean some cancer medications are not available, and patients are unable to get essential care. It is also unclear if these changes would save only some patients money or result in cost shifting onto patients with private insurance.  

“Dramatic changes to Medicare’s drug coverage should only be undertaken with careful consideration as to how such changes may affect patient access, especially for those with a history of cancer.    

“ACS CAN looks forward to an opportunity to comment on the full details of this proposal and will continue to evaluate the executive order to determine the potential impact on cancer patients and survivors.”  

 

More Press Releases AboutAccess to Health Care, National

Media Contacts

Allison Miller
Director, Media Advocacy
Washington, D.C.
[email protected]
202-585-3241
Alissa Crispino
Vice President, Media Advocacy & Communications
Washington, D.C.
[email protected]
202-661-5772

Related Press Releases

May 29, 2025

New York Lawmakers Remove Barriers to Lung Cancer Screening, Passing A1195-A / S2000-A

Earlier today, the New York State Senate voted to remove barriers to lung cancer screening in New York State, passing critical legislation to better equip New Yorkers to detect and treat lung cancer. S2000-A / A1195-A ensures comprehensive insurance coverage for lung cancer screening and eliminates cost sharing for recommended lung cancer screening, follow-up scans and diagnostic tests for asymptomatic individuals by all payers in the state.  

Read More
May 21, 2025

Medicaid Cuts Threaten Utahns – Cancer Advocates Urge Sen. Curtis to Oppose

Tuesday, Utah advocates with the American Cancer Society Cancer Action Network (ACS CAN) delivered nearly 1,000 petitions signed by constituents to Sen. John Curtis’ district office in Salt Lake City, urging him to protect Medicaid by opposing any cuts to the program. The postcards highlighted how looming cuts to Medicaid would harm Utahns, including working families, cancer patients and survivors, pregnant women, people with disabilities, seniors, veterans and children.

Read more
May 13, 2025

‘Cancer Action Day’ Brings Cancer Survivors to Harrisburg, Advocates Urge State & Federal Lawmakers to Preserve Access to Care

Over 120 volunteer advocates from across Pennsylvania, including cancer survivors, patients and caregivers, convened at the state Capitol yesterday for ‘Cancer Action Day,’ an event hosted annually by the American Cancer Society Cancer Action Network (ACS CAN). Advocates met with their state lawmakers and urged them to support policies that aid in the fight against cancer. 

Read more